Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 700713
                    [Title] => Novartis partners with TMC to enhance  gastrointestinal stromal tumor mg't
                    [Summary] => 
Research-based health care company Novartis has partnered with The Medical City (TMC) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
                    [DatePublished] => 2011-06-30 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

CANCER PROGRAM

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 700713
                    [Title] => Novartis partners with TMC to enhance  gastrointestinal stromal tumor mg't
                    [Summary] => 
Research-based health care company Novartis has partnered with The Medical City (TMC) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
                    [DatePublished] => 2011-06-30 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Novartis partners with TMC to enhance gastrointestinal stromal tumor mg't

June 30, 2011 - 12:00am

Research-based health care company Novartis has partnered with The Medical City (TMC) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.

Science and Environment